A Chinese bank is offering customers a Pfizer COVID-19 vaccine if they deposit $500,000 into an account
Other benefits for customers include a body check-up and the hepatitis B vaccine. Customers who apply for and activate a CNCBI GBA Currency Credit Card can getthe Pfizer vaccine or hepatitis B vaccine, as well as a 15% discount at the Four Seasons Hotel Hong Kong.
Other"privileges" for customers include four complimentary tickets to the theme park Monopoly Dreams Hong Kong and the chance to test drive a Bentley.Since China rolled back its strict zero-COVID policy last December, the country has seen
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Musk, Bezos and other tech billionaires lost over $500 billion of wealth in 2022Billionaires who added trillions to their personal fortunes during the pandemic saw their fortunes slide in 2022 and 2023 could be no better.
Read more »
This $500 'Rubik's Cube' Plays a Mind-Bending Version of Pac-Man (and More)The WOWCube has 24 independent touch screen displays and tracks when you twist, touch, or shake it.
Read more »
Ulta Beauty Email Scam Promises $500 Gift CardThe email phishing scam led to a survey that asked for a credit card number, which we strongly advise against providing to suspicious websites.
Read more »
Pfizer working to send COVID pill Paxlovid to China - CNBCPfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday.
Read more »
Twitter Files: Pfizer board member Dr. Scott Gottlieb flagged tweets questioning COVID vaccineAlex Berenson was the latest writer to be tapped by Elon Musk to dive into Twitter's archives, showing Dr. Scott Gottlieb, a Pfizer board member, targeting vaccine skepticism.
Read more »
Pfizer CEO rules out generic COVID drug Paxlovid for ChinaPfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said on Monday.
Read more »